206 related articles for article (PubMed ID: 1826353)
1. [Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Sagnol P; Delahaye JP
Presse Med; 1991 Feb; 20(7):287-90. PubMed ID: 1826353
[No Abstract] [Full Text] [Related]
2. [Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Davì G; Botindari G; Catalano I; Strano A
Cardiologia; 1988 Feb; 33(2):123-6. PubMed ID: 3282656
[No Abstract] [Full Text] [Related]
3. Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Buring JE; Hennekens CH
Circulation; 1990 Sep; 82(3):1046-8. PubMed ID: 2393990
[No Abstract] [Full Text] [Related]
4. [Role of platelet anti-aggregants in cardiovascular surgery].
Limet R
Rev Med Liege; 1987 May; 42(10):493-5. PubMed ID: 3497419
[No Abstract] [Full Text] [Related]
5. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
[No Abstract] [Full Text] [Related]
7. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
[TBL] [Abstract][Full Text] [Related]
8. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
Stein PD; Dalen JE; Goldman S; Théroux P
Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
[TBL] [Abstract][Full Text] [Related]
11. Platelet-inhibitory therapy in reconstructive arterial surgery.
McCollum CN; Goldman M
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
[No Abstract] [Full Text] [Related]
12. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Loeliger EA
Lancet; 1993 Sep; 342(8874):806; author reply 807. PubMed ID: 8103893
[No Abstract] [Full Text] [Related]
13. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Houben JJ; Nicolai G
Lancet; 1993 Sep; 342(8874):806-7. PubMed ID: 8103894
[No Abstract] [Full Text] [Related]
14. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
[TBL] [Abstract][Full Text] [Related]
15. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Loeliger EA
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
[No Abstract] [Full Text] [Related]
16. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery.
Refiker M
Am Heart J; 2011 May; 161(5):e25; author reply e27. PubMed ID: 21570501
[No Abstract] [Full Text] [Related]
17. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
Thromb Res Suppl; 1990; 12():11-21. PubMed ID: 2082483
[TBL] [Abstract][Full Text] [Related]
18. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
[TBL] [Abstract][Full Text] [Related]
19. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
Visser J
Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
[No Abstract] [Full Text] [Related]
20. [Anticoagulant, antiplatelet agents].
Ishikawa K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
